Dive into the data behind the landmark nine-year TRACERx study into lung cancer 🔍 Professor Charles Swanton, the project’s lead researcher and our chief clinician, said: “The study recognises that cancer isn’t static – and the way we treat patients shouldn’t be either.” To make their discoveries, Professor Swanton’s team at The Francis Crick Institute and UCL looked at a huge range of people affected by lung cancer. That's why TRACERx involved over 800 participants at 13 UK hospital sites, and